Multiple Sclerosis Journal · 2006 · 45 citations · 37 references
Life SciencesMolecular BiologyNeuroscienceAutoimmunityGene ExpressionNeurodegenerationMultiple SclerosisNeurodegenerative DiseasesNeurodegenerative DisordersEnzymesExtracellular Matrix DegradationImmunohistochemical MarkersImmunohistochemical StainingMatrix MetalloproteinasesMultiple Sclerosis PathologyProtein Expression LevelsWestern Blotting
ADAMTS (a disintegrin and metalloproteinase with thrombospondin motifs) -1, -4 and -5 proteases have been identified in the CNS at the mRNA level. These glutamyl endopeptidases, inhibited by tissue inhibitor of metalloproteinases (TIMP)-3, are key enzymes in the degradation of the aggregating chondroitin sulphate proteoglycans (CSPGs), and may therefore play a role in CNS extracellular matrix (ECM) changes in multiple sclerosis (MS). We have investigated ADAMTS and TIMP-3 expression in normal and MS CNS white matter by real-time RT-PCR, western blotting and immunohistochemistry. We report for the first time the presence of ADAMTS-1, -4 and -5 in normal and MS white matter. Levels of ADAMTS-1 and -5 mRNA were decreased in MS compared to normal tissue, with no significant change in ADAMTS-4 mRNA levels. Protein levels of ADAMTS-4 were significantly higher in MS tissue compared to normal tissue. Immunohistochemical studies demonstrated that ADAMTS-4 was associated predominantly with astrocytes with increased expression within MS lesions. TIMP-3 mRNA was significantly decreased in MS compared to controls. These studies suggest a role for ADAMTS-4 in the pathogenesis of MS. Further studies on the activity of ADAMTS-4 will enable a better understanding of its role in the turnover of the ECM of white matter in MS.
37
TNF‐α converting enzyme (TACE) is inhibited by TIMP‐3
Augustin Amour, Patrick M. Slocombe, Ailsa Webster et al. · FEBS Letters · 1998 · 607 citations
John D. Sandy, Jennifer Westling, Richard D. Kenagy et al. · Journal of Biological Chemistry · 2001 · 457 citations · Full text